Focused Medical Communications StemScientific specializes in publication planning and implementation within medical communications, presenting a clear opportunity to offer broader publication services, strategic advisory, and integrated communication programs to biopharma clients seeking end-to-end support.

Part of Network As a unit of Ashfield Healthcare Communications within UDG Healthcare, StemScientific can leverage cross-sell opportunities for larger strategic initiatives, including medical affairs, field medical activities, and global publication governance across multiple therapeutic areas.

Small Revenue, Growth Potential With revenue under one million dollars, there is substantial upside through expanded service lines, higher-value projects, and tiered retainer models targeting mid-size biotech firms and emerging companies seeking robust publication programs.

Industry Fit Serving pharmaceutical and biotech clients positions StemScientific well to pursue opportunities with mid-to-large CROs and equipment suppliers in the life sciences ecosystem that require medical communications support for trials, publications, and scientific storytelling.

Competitive Positioning Target similar mid-market players and adjacent service providers to extend Ashfield’s global capabilities; emphasize specialized expertise in publication planning, streamlined execution, and integration with broader clinical communications offerings.